Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05743270
Title Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Replimune Inc.
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP | DEU

No variant requirements are available.